Easton Pharmaceuticals Inc EAPH:Over The Counter Mkt

*Data is delayed | Exchange | USD
Last | 04/24/24 EDT
0.00UNCH (UNCH)
52 week range
0.00 - 0.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.00
  • 52 Week High0.00
  • 52 Week High Date04/19/24
  • 52 Week Low0.00
  • 52 Week Low Date04/24/24

Key Stats

  • Market Cap1,309.122
  • Shares Out1.31B
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-6.56
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.00
  • 52 Week High0.00
  • 52 Week High Date04/19/24
  • 52 Week Low0.00
  • 52 Week Low Date04/24/24
  • Market Cap1,309.122
  • Shares Out1.31B
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-6.56
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-171,949.998
  • ROE (TTM)-396.70%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Easton Pharmaceuticals Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Easton Pharmaceuticals, Inc. is a development-stage company engaged in various pharmaceutical sectors and others industries. The Company has a transdermal delivery technology (Viorra Delivery Matrix or VDM), which is incorporated in a line of therapeutic over-the-counter (OTC) products. The Company owns topically-delivered drugs and therapeutic/cosmetic healthcare products focused on cancer and other health problems geared towards female sexual dysfunction, wound healing...
John Adams
President, Chief Executive Officer
Neil Mellor
Chief Operating Officer
Walter Folinski
Chief Financial Officer
Susan Whyte
Vice President - Marketing
Address
650 Bay St
Toronto, ON
M4W 1A8
Canada